Peptron

087010.KQ

123.74 USD

0.61

+0.50%

Overview

Last close

123.74 usd

Market cap

1.90B usd

52 week high

126.56 usd

52 week low

16.05 usd

Target price

24.58 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1149.6237

Price/Book Value

26.7123

Enterprise Value

2.77B usd

EV/Revenue

1249.2367

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.08M usd

Gross Profit TTM

3.14M usd

EBITDA TTM

-7.54M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

114.58M usd

Net debt

5.43M usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.